Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AZ Health vs Hims & Hers

AZ Health
Graded #133

Lower grade

vs+12
Hims & Hers
Graded #36

Higher grade

The verdict

Hims & Hers takes it — 81/100 to 69/100.

Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHims & Hers +9
73
82
Dose & formulationHims & Hers +6
72
78
Clinical oversightHims & Hers +7
75
82
Labs & monitoringHims & Hers +28
52
80
FulfillmentHims & Hers +12
72
84
Contract termsHims & Hers +19
61
80
AZ Health · left barHims & Hers · right bar

The numbers

MetricAZ HealthHims & Hers
WeighScore69/10081/100
GradeCB−
Scorecard rank#133#36
Semaglutide$179/mo (all doses, compounded)$199/mo
Tirzepatide$199/mo (all doses, compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
AZ Health

Graded #133 · C

Strengths

  • Transparent flat monthly pricing — semaglutide from $179/mo, tirzepatide from $199/mo, no insurance required
  • Discloses that compounded medications are not FDA-approved and require a prescription
  • FSA/HSA eligible, free discreet shipping, and cancel anytime
  • Ongoing physician check-ins; also offers NAD+ injections

Where it loses points

  • LegitScript certification is self-stated on the site and not independently verifiable
  • Single-page site with no published Terms, Privacy, or HIPAA policy
  • Compounding pharmacy partner not named (states only 'FDA-registered pharmacies')
  • Legal entity not disclosed; availability limited (~half of US states, Arizona-focused)
Hims & Hers

Graded #36 · B−

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

Where it loses points

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard